Berkshire Hathaways Portfolio ShakeUp Delta Air Lines and Alphabet Moves in Focus Debasement Trade Loses Luster as Gold and Bitcoin ETFs See Outflows Indias Gen Z Discontent Fuels Cockroach Movement Amid Website Takedown Indias REITs Expanding Beyond Offices A Potential Wealth Creation Avenue for Retail Investors Berkshire Hathaway Overhauls Portfolio 26 Billion Delta Stake and 224 Alphabet Boost CapitaLand Unveils S14 Billion Life Sciences Hub Geneo to Drive Innovation Faraday Future Intelligent Electric Inc Q1 2026 Earnings EPS Surprise Positive but Revenue Remains Elusive Stock Drops CUK Q1 2026 Earnings EPS Meets Estimate Narrowly Stock Lifts 66 TPST Q1 2026 Earnings Deep EPS Miss Highlights ClinicalStage Biotech Challenges IsoEnergy Q1 2026 Earnings Narrower Than Expected Loss as Uranium Developer Advances Projects FormFactor Inc Q1 2026 Earnings EPS Surges Past Estimates Sending Shares Higher Atlanticus Holdings Senior Notes ATLCL Q1 2026 Earnings EPS Surges Past Estimates with 258 Beat Franklin Limited Duration Income Trust FTF Edges Higher as Yield Seekers Reassess Rate Outlook Arcturus Therapeutics ARCT Surges 62 as Buyers Defend Key Support Supervielle SUPV Pulls Back 514 as Shares Test Key Support Levels CF Financial CFFI Rallies Above Key Moving Averages Testing Resistance Zone MasterBrand Inc MBC Surges Over 7 Resistance and Support in Focus Oura Health Files Confidentially for IPO Signaling Growth in Wearable Tech Market AI Economy Reshapes Job Market BlueCollar Skilled Trades Gain as WhiteCollar Entry Roles Slow Perpetua Resources Secures 29 Billion US Loan for Critical Minerals Project in Idaho European Gas Storage at Risk If Hormuz Disruption Persists Analysis UnitedHealth Group UNH Picked as Top Dividend Stock by Hedge Funds Mizuho Lifts Price Target to 440 Italian Top Court Ruling on Tap Water Could Reshape Hospitality Practices in Dolomites Stocks Edge Higher on Solid Fundamentals Market Rally Continues HIG Q1 2026 Earnings EPS Misses Estimates by 10 Stock Unchanged Amid Mixed Signals Cartesian Therapeutics RNAC Gains 46 as Biotech Sector Shows Renewed Interest